Intellectual Property Magazine
Moderna loses bid to invalidate mRNA patents
Hannah Gannage-Stewart
The US Court of Appeals for the Federal Circuit has rejecteda bid by Moderna to invalidate two Arbutus Biopharma patents that
may be relatedto its Covid-19 vaccine.